Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
This study will use a randomized controlled trial design to evaluate the effect of two evidence-based treatments for adults with mild-moderate Primary Progressive Aphasia (PPA). The aim of the study is to help us better understand the effects of speech-language therapy on communication abilities in individuals with PPA.
Full description
Participants with a diagnosis of PPA and their actively-engaged care partners will be involved in the study for approximately 17 months. Each participant will receive a laptop equipped with the necessary applications and features for the study. Participants will receive up to 10 evaluations and 20 speech therapy sessions with a licensed speech therapist, as well as access to Communication Bridge, a personalized web application to practice home exercises that reinforce treatment strategies. There are no costs to participate in this study.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria (person with PPA):
Inclusion Criteria (Co-enrolled communication partner):
Exclusion Criteria:
Medical records will be requested and reviewed to determine eligibility
Primary purpose
Allocation
Interventional model
Masking
200 participants in 2 patient groups
Loading...
Central trial contact
Emily Cummings; Matthew Bona, MPH
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal